Santen Pharmaceutical Co., Ltd. announced that its Board of Directors has approved the following management changes: Akira Kurokawa appointed as Chairman and Chief Executive Officer from President and Chief Executive Officer and Shigeo Taniuchi appointed as President and Chief Operating Officer from Member of the Board, Senior Corporate Officer of the company. The changes are being made in order to best position Santen to realize its long-term strategic "Vision 2020" to becoming a specialty company with a global presence; improving its business execution capabilities in its upcoming mid-term management plan under accelerating globalization; and achieve long-term, sustainable growth.